Karyopharm completes endometrial cancer trial enrollment, reports Q1 results

May 14, 2026 7:30 AM

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) reported first quarter 2026 financial results and announced completion of enrollment in its Phase 3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found